Reverse Payment Patent Settlements: The Supreme Court Has Spoken

Reverse Payment Patent Settlements: The Supreme Court Has Spoken

Speaking Engagement
On June 17, 2013, the Supreme Court issued its long-awaited decision in FTC v. Actavis. After years of litigation in the lower courts, this is the first time the Court weighed in on the antitrust treatment of “reverse payment” (sometimes also known as “pay-for-delay”) patent settlements between branded and generic pharmaceutical manufacturers. This panel discussion, sponsored by the ABA Section of Antitrust Law’s Health Care and Pharmaceuticals Committee, provides a first analysis of the Court’s landmark decision.

WilmerHale Partner Hartmut Schneider moderated this event.

Read More About the Event

Speakers